Astonea Labs Reports Strong Half-Year Results and Appoints Three New Directors
Astonea Labs Limited announced unaudited financial results for H1 2025, showing a 40.20% year-over-year increase in revenue from operations to Rs 66.29 crores. The company appointed three new Non-Executive, Non-Independent Directors: Mr. Arun Kumar Tripathi, Mr. Pardeep Dalal, and Mr. Vikrant, effective November 10, 2025, subject to shareholder approval. The board also authorized Ms. Pooja Singh to finalize a revised distribution agreement with Astonea One Private Limited.

*this image is generated using AI for illustrative purposes only.
Astonea Labs Limited, a manufacturer and seller of cosmetics and pharmaceutical products, has announced its unaudited financial results for the half-year ended September 30, 2025, along with significant changes to its board of directors.
Financial Performance
The company reported a substantial increase in its revenue from operations for the half-year period:
| Metric | H1 2025 | H1 2024 | YoY Growth |
|---|---|---|---|
| Revenue from Operations | 66.29 | 47.27 | 40.20% |
| Net Profit | 1.47 | Not provided | N/A |
All figures in Rs crores
The significant year-over-year growth of 40.20% in revenue demonstrates strong performance in the company's core business activities.
Board Appointments
Astonea Labs has appointed three new Non-Executive, Non-Independent Directors to its board, effective from November 10, 2025, subject to shareholder approval at the next Annual General Meeting:
Mr. Arun Kumar Tripathi (DIN: 08786789)
- Age: 40 years
- Qualification: Bachelor's degree in Pharmacy (B.Pharm)
- Experience: Extensive experience in manufacturing pharmaceutical and cosmetic products
Mr. Pardeep Dalal (DIN: 02424111)
- Age: 40 years
- Qualification: Bachelor's degree in Arts
- Experience: Professional experience in finance
Mr. Vikrant (DIN: 08686283)
- Age: 39 years
- Qualification: Degree in Dairy Science
- Experience: Extensive professional experience in research and formulation of pharmaceutical and cosmetic products
These appointments are expected to bring diverse expertise to the company's board, potentially contributing to its growth and strategic direction.
Other Key Developments
The board has authorized Ms. Pooja Singh to finalize a revised distribution agreement with Astonea One Private Limited, which may impact the company's distribution strategy.
The company's board meeting on November 10, 2025, lasted from 12:30 PM to 1:45 PM.
Astonea Labs Limited, formerly known as Astonea Labs Private Limited, continues to focus on its core business of manufacturing and selling cosmetics and pharmaceutical products. The company's strong financial performance and strategic board appointments indicate its commitment to growth and corporate governance.
Investors and stakeholders will be keen to observe how these new appointments and the revised distribution agreement may influence the company's future performance and market position in the competitive pharmaceutical and cosmetics industry.
Historical Stock Returns for Astonea Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.28% | +5.48% | +6.21% | +4.23% | +13.53% | +13.53% |




























